On Oct 25, major Wall Street analysts update their ratings for $Labcorp Holdings (LH.US)$, with price targets ranging from $249 to $289.
Morgan Stanley analyst Erin Wright maintains with a buy rating, and maintains the target price at $260.
BofA Securities analyst Michael Ryskin maintains with a buy rating, and sets the target price at $262.
Barclays analyst Stephanie Davis maintains with a hold rating, and adjusts the target price from $234 to $249.
Mizuho Securities analyst Ann Hynes maintains with a buy rating.
Baird analyst Eric Coldwell maintains with a buy rating, and adjusts the target price from $282 to $289.
Furthermore, according to the comprehensive report, the opinions of $Labcorp Holdings (LH.US)$'s main analysts recently are as follows:
The expectation is that Labcorp may gain from the increased demand for dependable healthcare services as the year draws to a close, following their third-quarter financial report.
Labcorp's recent quarterly update indicated robust Diagnostic sector performance and enhanced BLS P&L results, in spite of largely transient challenges.
Here are the latest investment ratings and price targets for $Labcorp Holdings (LH.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
